National Comprehensive Cancer Network Updates Myelodysplastic Syndromes (MDS) Guidelines

JENKINTOWN, Pa.--(BUSINESS WIRE)--The National Comprehensive Cancer Network (NCCN) announces important updates to the NCCN Myelodysplastic Syndromes (MDS) Guidelines. The NCCN Clinical Practice Guidelines in Oncology™ are widely recognized and applied as the standard of care in oncology in the United States in both the community and the academic practice settings. These guidelines are updated continually and are based upon evaluation of scientific data integrated with expert judgment.

Back to news